Expression of CD19 and lack of miR-223 distinguish extramedullary plasmacytoma from multiple myeloma

Histopathology

Volumn 58, Issue 6, 2011, Pages 896-905

  Yu, Shan Chi ^a   Chen, Shee Uan ^a   Lu, Wen ^a   Liu, Ting Yun ^a   Lin, Chung Wu ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

CD19; Extramedullary plasmacytoma; MicroRNAs; Multiple myeloma

Indexed keywords

CD19 ANTIGEN; MICRORNA; MICRORNA 223; UNCLASSIFIED DRUG;

ADULT; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; CLINICAL ARTICLE; DIFFERENTIAL DIAGNOSIS; EXTRAMEDULLARY PLASMACYTOMA; FEMALE; GERMINAL CENTER; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE DIFFERENTIATION; MALE; MEMORY CELL; MULTIPLE MYELOMA; PLASMA CELL; PLASMACYTOMA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTIGENS, CD19; B-LYMPHOCYTES; CELL DIFFERENTIATION; DIAGNOSIS, DIFFERENTIAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICRORNAS; MIDDLE AGED; MULTIPLE MYELOMA; PHENOTYPE; PLASMACYTOMA; PROGNOSIS; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 79956110879     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2011.03793.x     Document Type: Article

References (28)

1. McKenna RW, Kyle RA, Kuehl WM et al. Plasma cell neoplasms. In Swerdlow SH, Campo E, Harris NL eds. World Health Organization classification of tumours: pathology and genetics of tumours of haematopoietic and lymphoid tissue, 4th edn. Lyon: IARC Press, 2008; 200-213.
2. Alexiou C, Kau RJ, Dietzfelbinger H et al. Extramedullary plasmacytoma: tumor occurrence and therapeutic concepts. Cancer 1999; 85; 2305-2314.
3. Ozsahin M, Tsang RW, Poortmans P et al. Outcomes and patterns of failure in solitary plasmacytoma: a multicenter rare cancer network study of 258 patients. Int. J. Radiat. Oncol. Biol. Phys. 2006; 64; 210-217.
4. Shih LY, Dunn P, Leung WM et al. Localised plasmacytomas in Taiwan: comparison between extramedullary plasmacytoma and solitary plasmacytoma of bone. Br. J. Cancer 1995; 71; 128-133.
5. Strojan P, Soba E, Lamovec J et al. Extramedullary plasmacytoma: clinical and histopathologic study. Int. J. Radiat. Oncol. Biol. Phys. 2003; 53; 692-701.
6. Lin P, Owens R, Tricot G et al. Flow cytometric immunophenotypic analysis of 306 cases of multiple myeloma. Am. J. Clin. Pathol. 2004; 121; 482-488.
7. Van Camp B, Durie BG, Spier C et al. Plasma cells in multiple myeloma express a natural killer cell-associated antigen: CD56 (NKH-1; Leu-19). Blood 1990; 76; 377-382.
8. Seegmiller AC, Xu Y, McKenna RW et al. Immunophenotypic differentiation between neoplastic plasma cells in mature B-cell lymphoma vs plasma cell myeloma. Am. J. Clin. Pathol. 2007; 127; 176-181.
9. Sakai A, Fujii T, Noda M et al. Plasma cells composing plasmacytoma have phenotypes different from those of myeloma cells. Am. J. Hematol. 1996; 53; 251-253.
10. Kremer M, Ott G, Nathrath M et al. Primary extramedullary plasmacytoma and multiple myeloma: phenotypic differences revealed by immunohistochemical analysis. J. Pathol. 2005; 205; 92-101.
11. Hussong JW, Perkins SL, Schnitzer B et al. Extramedullary plasmacytoma: a form of marginal zone cell lymphoma? Am. J. Clin. Pathol. 1999; 111; 111-116.
12. Garzon R, Croce CM. MicroRNAs in normal and malignant hematopoiesis. Curr. Opin. Hematol. 2008; 15; 352-358.
13. Zhang J, Jima DD, Jacobs CF et al. Patterns of microRNA expression characterize stages of human B-cell differentiation. Blood 2009; 113; 4586-4594.
14. Malumbres R, Sarosiek KA, Cubedo E et al. Differentiation stage-specific expression of microRNAs in B lymphocytes and diffuse large B-cell lymphomas. Blood 2009; 113; 3754-3764.
15. Pichiorri F, Suh SS, Ladetto M et al. MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis. Proc. Natl Acad. Sci. USA 2008; 105; 12885-12890.
16. Roccaro AM, Sacco A, Thompson B et al. MicroRNAs 15a and 16 regulate tumor proliferation in multiple myeloma. Blood 2009; 113; 6669-6680.
17. Bartl R, Frisch B, Fateh-Moghadam A et al. Histologic classification and staging of multiple myeloma: a retrospective and prospective study of 674 cases. Am. J. Clin. Pathol. 1987; 87; 342-355.
18. Chen C, Ridzon DA, Broomer AJ et al. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res. 2005; 33; e179.
19. Kobayashi S, Hyo R, Amitani Y et al. Four-color flow cytometric analysis of myeloma plasma cells. Am. J. Clin. Pathol. 2006; 126; 908-915.
20. Harada H, Kawano MM, Huang N et al. Phenotypic difference of normal plasma cells from mature myeloma cells. Blood 1993; 81; 2658-2663.
21. Medina F, Segundo C, Salcedo I et al. Purification of human lamina propria plasma cells by an immunomagnetic selection method. J. Immunol. Methods 2004; 285; 129-135.
22. Farstad IN, Carlsen H, Morton HC et al. Immunoglobulin A cell distribution in the human small intestine: phenotypic and functional characteristics. Immunology 2000; 101; 354-363.
23. Woehrer S, Streubel B, Chott A et al. Transformation of MALT lymphoma to pure plasma cell histology following treatment with the anti-CD20 antibody rituximab. Leuk. Lymphoma 2005; 46; 1645-1649.
24. Bink K, Haralambieva E, Kremer M et al. Primary extramedullary plasmacytoma: similarities with and differences from multiple myeloma revealed by interphase cytogenetics. Haematologica 2008; 93; 623-626.
25. Lionetti M, Biasiolo M, Agnelli L et al. Identification of microRNA expression patterns and definition of a microRNA/mRNA regulatory network in distinct molecular groups of multiple myeloma. Blood 2009; 114; e20-e26.
26. Bryant A, Lutherborrow M, Ma D. The clinicopathological relevance of microRNA in normal and malignant haematopoiesis. Pathology 2009; 41; 204-213.
27. Krenacs L, Himmelmann AW, Quintanilla-Martinez L et al. Transcription factor B-cell-specific activator protein (BSAP) is differentially expressed in B cells and in subsets of B-cell lymphomas. Blood 1998; 92; 1308-1316.
28. Torlakovic E, Torlakovic G, Nguyen PL et al. The value of anti-Pax-5 immunostaining in routinely fixed and paraffin-embedded sections: a novel pan pre-B and B-cell marker. Am. J. Surg. Pathol. 2003; 26; 1343-1350.